Lupus Handbag Luncheon Supports Science in Style
They showed style. They showed grace. But more important, attendees of the 8th Annual Lupus Handbag Luncheon and Silent...
Search Results
You searched for: Research Portfolio
Results found: 856
New Study Led by LRA Scientific Advisor Explores the Role of Little-Studied Molecular Reactions in Preventing Organ Damage in Lupus
November 13, 2018
While much basic autoimmune research has focused on ways to foil the bad behavior of immune cells,...
Hydroxychloroquine: Common Lupus Drug in Testing for COVID-19
March 19, 2020
In December 2019, a new virus called SARS-COV-2 was identified in Wuhan, China. This virus was found...
Molecular fingerprinting of lupus in children
This grant was awarded to an international team comprised of 10 investigators at five prestigious academic medical centers. Led...
Potential New Lupus Treatment Outperforms Hydroxychloroquine in Animal Study
November 28, 2018
Anti-malaria drugs such as hydroxychloroquine are common treatments for arthritis and heat rash in patients with lupus....
Differences Found in Genes Among African and European Americans Point to Possible Lupus Drug Targets
November 10, 2020
Lupus affects individuals differently, from disease symptoms to responses to treatments. Lupus patients of African ancestry often...
New Survey Shows Education and Communication Gaps in Lupus Nephritis Care
1 in 2 Lupus Nephritis Patients Don’t Know They Have Lupus
New York, NY– December 7, 2020. Significant gaps in...
Lupus Gains a Strong Advocate in Physician/Researcher Dr. Ashira Blazer
February 25, 2021
Dr. Ashira Blazer is literally a rising star. This year, she won the 40 Under 40 Leaders...
Gazyva® Shows Positive Results in Phase 3 Lupus Nephritis Trial
The Lupus Research Alliance (LRA) and clinical research affiliate Lupus Therapeutics (LT) are excited to share positive news of...
LRA-Supported Study Finds Similarities in the Immune Response Between Severe COVID-19 and Lupus Antiphospholipid Syndrome
December 2, 2020
The immune response during severe COVID-19 is similar to a lupus complication known as antiphospholipid syndrome, according...
Analysis Found Rituximab Biosimilar Showed Effectiveness in Treating Pediatric Lupus Nephritis
Rituximab biosimilar BCD020 showed effectiveness in treating lupus nephritis in a pediatric population according to results of a retrospective...
Learning to Self-Advocate in the Transition from Pediatric to Adult Lupus Care by Denita Perry
November 29, 2018
Making the transition from being a young person with lupus to an adult is something that many...